MSI Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MSI Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$27K	Hold	1,647	–	–	﹤0.01%	2233
2016 Q3	$30K	Sell	1,647 -1	-0.1%	-$20	﹤0.01%	2137
2016 Q2	$27K	Buy	1,648 +568	+53%	+$9.19K	﹤0.01%	2176
2016 Q1	$18K	Sell	1,080 -472	-30%	-$8.26K	﹤0.01%	2390
2015 Q4	$34K	Sell	1,552 -696	-31%	-$13.5K	﹤0.01%	1977
2015 Q3	$45K	Buy	2,248 +1,944	+639%	+$61.4K	﹤0.01%	1268
2015 Q2	$11K	Buy	304 +300	+7,500%	+$9.15K	﹤0.01%	2100
2015 Q1	$0	Buy	4 +3	+300%	+$55	﹤0.01%	3199
2014 Q4	$0	Buy	+1	New	+$13	﹤0.01%	2847

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's HZNP Position: Q4 2016 in Review

MSI Financial Services held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q4 2016 at 1,647 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

MSI Financial Services first reported a position in HZNP in Q4 2014 and has held it in 9 quarters since. The position peaked at $45K in Q3 2015. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

MSI Financial Services held 1,647 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $27K as of Q4 2016.
MSI Financial Services left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q4 2016.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2233 holding.
MSI Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and has held it in 9 quarters since.
MSI Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $45K in Q3 2015.
234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.